A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network
一项多国参与的 II 期随机适应性试验方案，旨在评估不同 COVID-19 疫苗在已接种过 SARS-CoV-2 疫苗的 75 岁及以上成年人中的免疫原性和反应原性（EU-COVAT-1-AGED）：该试验在 VACCELERATE 网络内开展。
期刊:Trials
影响因子:2
doi:10.1186/s13063-022-06791-y
Neuhann, Julia M; Stemler, Jannik; Carcas, Antonio; Frías-Iniesta, Jesús; Bethe, Ullrich; Heringer, Sarah; Tischmann, Lea; Zarrouk, Marouan; Cüppers, Arnd; König, Franz; Posch, Martin; Cornely, Oliver A
